Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA - NYSE:CRBD - US21871X2080

24.84 USD
-0.11 (-0.44%)
Last: 10/22/2025, 7:24:52 PM
Fundamental Rating

4

Overall CRBD gets a fundamental rating of 4 out of 10. We evaluated CRBD against 99 industry peers in the Financial Services industry. CRBD may be in some trouble as it scores bad on both profitability and health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CRBD.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRBD was profitable.
In the past year CRBD had a positive cash flow from operations.
Each year in the past 5 years CRBD has been profitable.
CRBD had a positive operating cash flow in each of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of CRBD (-0.08%) is worse than 73.74% of its industry peers.
Looking at the Return On Equity, with a value of -2.74%, CRBD is doing worse than 76.77% of the companies in the same industry.
CRBD has a Return On Invested Capital of 0.20%. This is in the lower half of the industry: CRBD underperforms 68.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRBD is significantly below the industry average of 7.79%.
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROIC 0.2%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBD's Profit Margin has improved in the last couple of years.
CRBD has a Operating Margin of 7.02%. This is in the lower half of the industry: CRBD underperforms 62.63% of its industry peers.
CRBD's Operating Margin has improved in the last couple of years.
CRBD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 7.02%
PM (TTM) N/A
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRBD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CRBD has been reduced compared to 1 year ago.
CRBD has less shares outstanding than it did 5 years ago.
CRBD has a worse debt/assets ratio than last year.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CRBD is 6.76, which is on the high side as it means it would take CRBD, 6.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.76, CRBD is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
A Debt/Equity ratio of 0.92 indicates that CRBD is somewhat dependend on debt financing.
CRBD's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. CRBD outperforms 47.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Altman-Z N/A
ROIC/WACC0.03
WACC6.18%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CRBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.75%, which is quite good.
CRBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 115.54% yearly.
The Revenue for CRBD has decreased by -16.47% in the past year. This is quite bad
The Revenue has been growing by 8.01% on average over the past years. This is quite good.
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%

3.2 Future

The Earnings Per Share is expected to grow by 10.21% on average over the next years. This is quite good.
CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.39% yearly.
EPS Next Y3.67%
EPS Next 2Y8.72%
EPS Next 3Y11.27%
EPS Next 5Y10.21%
Revenue Next Year-7.49%
Revenue Next 2Y-1.64%
Revenue Next 3Y-0.45%
Revenue Next 5Y3.39%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.84, the valuation of CRBD can be described as very cheap.
Based on the Price/Earnings ratio, CRBD is valued cheaply inside the industry as 95.96% of the companies are valued more expensively.
CRBD is valuated cheaply when we compare the Price/Earnings ratio to 27.57, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 4.34, the valuation of CRBD can be described as very cheap.
92.93% of the companies in the same industry are more expensive than CRBD, based on the Price/Forward Earnings ratio.
CRBD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.09.
Industry RankSector Rank
PE 4.84
Fwd PE 4.34
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRBD's Enterprise Value to EBITDA ratio is in line with the industry average.
CRBD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRBD is cheaper than 78.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.97
EV/EBITDA 18.63
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.32
PEG (5Y)0.04
EPS Next 2Y8.72%
EPS Next 3Y11.27%

2

5. Dividend

5.1 Amount

CRBD has a Yearly Dividend Yield of 3.13%.
CRBD's Dividend Yield is a higher than the industry average which is at 5.15.
CRBD's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.13%

5.2 History

CRBD is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CRBD are negative and hence is the payout ratio. CRBD will probably not be able to sustain this dividend level.
DP-156.08%
EPS Next 2Y8.72%
EPS Next 3Y11.27%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (10/22/2025, 7:24:52 PM)

24.84

-0.11 (-0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners86.58%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.38B
Revenue(TTM)14.66B
Net Income(TTM)-337000000
Analysts80
Price Target31.67 (27.5%)
Short Float %0%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 3.13%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP-156.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.55%
Min EPS beat(2)-0.44%
Max EPS beat(2)15.55%
EPS beat(4)3
Avg EPS beat(4)7.91%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.91%
EPS beat(12)10
Avg EPS beat(12)8.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-11.67%
Min Revenue beat(2)-11.92%
Max Revenue beat(2)-11.42%
Revenue beat(4)0
Avg Revenue beat(4)-14.95%
Min Revenue beat(4)-21.6%
Max Revenue beat(4)-11.42%
Revenue beat(8)2
Avg Revenue beat(8)-15.15%
Revenue beat(12)4
Avg Revenue beat(12)-7.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.19%
PT rev (3m)22.87%
EPS NQ rev (1m)-5.29%
EPS NQ rev (3m)-11.14%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)1.34%
Revenue NQ rev (1m)-1.65%
Revenue NQ rev (3m)-5.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.43%
Valuation
Industry RankSector Rank
PE 4.84
Fwd PE 4.34
P/S 0.91
P/FCF 7.97
P/OCF 7.97
P/B 1.09
P/tB 1.09
EV/EBITDA 18.63
EPS(TTM)5.13
EY20.65%
EPS(NY)5.72
Fwd EY23.03%
FCF(TTM)3.12
FCFY12.55%
OCF(TTM)3.12
OCFY12.55%
SpS27.22
BVpS22.85
TBVpS22.85
PEG (NY)1.32
PEG (5Y)0.04
Graham Number51.35
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -2.74%
ROCE 0.26%
ROIC 0.2%
ROICexc 0.2%
ROICexgc 0.3%
OM 7.02%
PM (TTM) N/A
GM N/A
FCFM 11.45%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3Y-24.91%
ROICexgc growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.76
Debt/EBITDA 8.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.78
Cash Conversion 128.19%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.18%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%20.35%
EPS Next Y3.67%
EPS Next 2Y8.72%
EPS Next 3Y11.27%
EPS Next 5Y10.21%
Revenue 1Y (TTM)-16.47%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%5.84%
Revenue Next Year-7.49%
Revenue Next 2Y-1.64%
Revenue Next 3Y-0.45%
Revenue Next 5Y3.39%
EBIT growth 1Y-41.6%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-55.04%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-55.04%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%